Corrigendum: A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale (Cardiology in the Young (2012) DOI: 10.1017/S1047951112000029);A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale

Cardiology in the Young

Volumn 22, Issue 3, 2012, Pages 327-334

  Mazzucco, Sara ^a   Bovi, Paolo ^b   Carletti, Monica ^c   Tomelleri, Giampaolo ^b   Golia, Giorgio ^c   Stegagno, Chiara ^d   Variola, Andrea ^c   Anselmi, Maurizio ^e   Nicolis, Daniele ^c   Olivato, Silvia ^a   Anzola, Gian Paolo ^f   Ribichini, Flavio ^c   Beltrame, Federico ^c   Benini, Adolfo ^c   Benussi, Paolo ^c   Moretto, Giuseppe ^c   Fiaschi, Antonio ^c   Loschiavo, Isabella ^c   Molinari, Gionata ^c   Pesarini, Gabriele ^c   Prioli, Antonia ^c   Rossi, Laura ^c   Vassanelli, Corrado ^c   more..

^a Section of Clinical Neurology   (Italy)

^b SSO Stroke Unit   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d Institute of Anatomic Pathology S Maria   (Italy)

^e San Bonifacio Hospital   (Italy)

^f S Orsola Hospital   (Italy)

Author keywords

multi disciplinary counselling; percutaneous atrial septal repair; Stroke in the young

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART RIGHT LEFT SHUNT; HEART SURGERY; HUMAN; INTERDISCIPLINARY COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PERCUTANEOUS ATRIAL SEPTAL REPAIR; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RECURRENCE RISK; STROKE PATIENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ALGORITHM; CLINICAL PROTOCOL; DECISION SUPPORT SYSTEM; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ITALY; MIDDLE AGED; RECURRENT DISEASE; STROKE; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK;

ADULT; ALGORITHMS; CLINICAL PROTOCOLS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FORAMEN OVALE, PATENT; HUMANS; INTERDISCIPLINARY COMMUNICATION; ISCHEMIC ATTACK, TRANSIENT; ITALY; MALE; MIDDLE AGED; RECURRENCE; STROKE; SURVIVAL RATE;

EID: 84866766898     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951112000340     Document Type: Erratum

References (40)

1. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152.
2. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112: 1063-1072.
3. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988; 2: 11-12.
4. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117: 461-465.
5. Kizer JR, Devereux RB. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med 2005; 353: 2361-2372.
6. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55: 1172-1179.
7. Handke M, Harloff A, Olschewski M, Hetzel Ageibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357: 2262-2268.
8. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurism and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991; 18: 1223-1229.
9. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004; 17: 231-233.
10. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischaemic stroke: a case-control study. Stroke 1998; 29: 1322-1328.
11. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 2006; 66: 765-767.
12. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Int Cardiol 2003; 16: 43-49.
13. Messe SR, Silverman IE, Kizer JR, et al. Quality standards subcommittee of the American Academy of Neurology: practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042-1050.
14. Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006; 47: 440-445.
15. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007; 49: 797-802.
16. ClinicalTrials.gov.http://clinicaltrials.gov/ct2/results?term5stroke1 and1PFO (last accessed January 23, 2012).
17. Furlan A. LBCT II, Abstract 21572. Presented at the American Heart Association Scientific Sessions 2010, Chicago, November 13-17.
18. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation 2002; 105: 2625-2631.
19. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
20. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces-revised recommendations 2004. Eur J Neurol 2004; 11: 577-581.
21. Italian Collaboration for Stroke PREvention and Awareness Diffusion (SPREAD). lctus cerebrale: linee guida italiane 2010, pp 1-151. http://www.spread.it/files/SPREAD62010sintesi.pdf (last accessed 23 January 2012).
22. Scottish Intercollegiate Guideline Network. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention. A national clinical guideline 2008, pp 1-108. http://www.sign.ac.uk/pdf/sign108.pdf (last accessed 23 January 2012).
23. Phillips, B, Ball, C, Sackett, D, et al. Oxford Centre for Evidence based Medicine Levels of Evidence (May 2001). http://www.cebm.net/ index.aspx?o51025 (Date of last access July 2010).
24. Kim WR, Valdiserri RO, Wright LN, Manos MM, Do ST. Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations. J Fam Pract 2010; 59(4 Suppl.): S43-S50.
25. Rigatelli G, Braggion G, Chinaglia M, et al. Setting up a multidisciplinary program for management of patent foramen ovale-mediated syndromes. J Interven Cardiol 2006; 19: 264-268.
26. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS). Eur Heart J 2010; 20: 2501-2555.
27. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 1993; 24: 35-41.
28. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24(Suppl. 1): 1-151.
29. Jauss M, Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000; 10: 490-496.
30. Rigatelli G, Dell'Avvocata F, Ronco F, Giordan M, Cardaioli P. Patent oval foramen transcatheter closure: results of a strategy based on tailoring the device to the specific patient's anatomy. Cardiol Young 2010; 20: 144-149.
31. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-390.
32. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really ''shut the door?'' A prospective study with transcranial Doppler. Stroke 2004; 35: 2140-2144.
33. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand W, Kleinman CS. PFO Closure complications from the AGA registry. Catheter Cardiovasc Int 2008; 72: 74-79.
34. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the EuropeanSociety of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28: 1462-1536.
35. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
36. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(Suppl. 1). S62-S67.
37. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2002). (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
38. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24: 1865-1873.
39. Serena J, Marti-Fabregas J, Santamarina E, et al. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke 2008; 39: 3131-3136.
40. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007; 100: 1364-1369.